By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
Interventional Glaucoma18.34M93.13%
Interventional Dry Eye1.35M6.87%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States77.36M100.00%